COMPANY PROFILE

Scap Hologram

Explore full profile

XR navigation for shoulder surgery

Saint-Martin-d'Hères, FranceFounded 2024Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Scap Hologram

Scap Hologram is a French medtech developing holographic and extended-reality navigation for shoulder arthroplasty. The system combines patient-specific CT-based planning with real-time intraoperative guidance so surgeons can visualize anatomy and instrument positioning during shoulder joint replacement.

Public coverage describes 3D holographic mapping of the surgical field, miniaturized tracking sensors (including GemTrack radiofrequency tracking developed with MinMaxMedical), and a workflow from preoperative imaging to live instrument guidance aimed at making computer-assisted shoulder surgery more ergonomic and less dependent on line-of-sight infrared cameras and invasive fixation. The company is based in the Grenoble / Saint-Martin-d’Hères medtech ecosystem.

Scap Hologram sells surgical navigation technology to orthopaedic providers and industry partners. The business model is medtech / digital surgery navigation. Public reports in May 2026 described a definitive agreement for sale of related assets to DePuy Synthes.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2024
Headquarters: Saint-Martin-d'Hères, France
Employees: 15
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, biotech medtech and e-health, Observatoire Deeptech, Woman Founder, DT and LS, observatoire healthtech, science-based
Client focus: b2b
Links: LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Oct 2025	$24M	$97M	Haventure · Fullstim · eCential Robotics · SUROSH	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Scap Hologram team growth

Scap Hologram's team grew 36.4% over the past year.

1-year team growth+36.4%

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OOOrakl OncologyTumor avatars to transform oncology drug development	Paris, France	Operational	38	$15M	$48M
DIDillicoA revolutionary approach to the scale-up and production of mRNA-based vaccine and therapeutics	Meylan, France	Operational
RIRibonexusA biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies in cancer patients	Villejuif, France	Closed
ALAllogenicaDevelopment of an emerging class of cancer therapy, called CAR-T cells	Villeurbanne, France	Operational
SCStroma CareCompany Strategy, Scientific Rationale and Therapeutic Candidate	Lyon, France	Operational
STStarkage TherapeuticsA privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation	Lille, France	Operational
PHphagosAI-powered bacteriophage therapies targeting antimicrobial resistance in animals	Suresnes, France	Operational
BDBiomadvanced DiagnosticsDisrupting the Field of Biomarkers Related to the Immune System	Nantes, France	Operational